Toyomasa Katagiri
Direttore/Membro del Consiglio presso Cancer Precision Medicine KK
Profilo
Toyomasa Katagiri is currently the Director at Immunas Pharma, Inc. since 2014, Professor & Deputy Director at The University of Tokushima since 2008, and Director at Cancer Precision Medicine KK since 2018.
Previously, he served as an Outside Director at OncoTherapy Science, Inc. from 2010 to 2023.
Posizioni attive di Toyomasa Katagiri
| Società | Posizione | Inizio |
|---|---|---|
| The University of Tokushima | Corporate Officer/Principal | 01/05/2008 |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Direttore/Membro del Consiglio | 01/12/2014 |
| Cancer Precision Medicine KK | Direttore/Membro del Consiglio | 01/05/2018 |
Precedenti posizioni note di Toyomasa Katagiri
| Società | Posizione | Fine |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direttore/Membro del Consiglio | 31/03/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Cancer Precision Medicine KK |
- Borsa valori
- Insiders
- Toyomasa Katagiri
